Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices
- PMID: 2073897
- DOI: 10.1007/BF01967501
Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices
Abstract
A significant increase in the use of vascular access devices has changed the spectrum of organisms causing bacteremia and fungemia at Memorial Sloan-Kettering Cancer Center. This paper documents the 1988 laboratory experience with bacteremia and fungemia and contrasts some of that data with information obtained in 1984. In 1988, 439 tunnelled-catheters and 355 ports were inserted in patients; 2,778 organisms were subsequently recovered from 933 episodes of bacteremia and fungemia. Fifty-percent of the episodes of bacteremia and fungemia were vascular access device-related. Compared to 1984, the relative incidence of bacteremia due to gram-positive organisms increased from 33 to 43%, polymicrobic cultures increased from 24 to 27%, and the number of organisms with colony counts greater than 100 cfu/ml increased from 24 to 44%. In 1988, device-related sepsis was often caused by Acinetobacter spp., Bacillus spp., Corynebacterium spp., pseudomonads other than Pseudomonas aeruginosa, and coagulase-negative staphylococci. Infection was also caused by species of flavobacteria, Micrococcus, and Rhodotorula. Efforts required for identification of many of the newer pathogens have escalated material and personnel costs.
Similar articles
-
Infectious morbidity associated with long-term use of venous access devices in patients with cancer.Ann Intern Med. 1993 Dec 15;119(12):1168-74. doi: 10.7326/0003-4819-119-12-199312150-00003. Ann Intern Med. 1993. PMID: 8239247
-
Relationship of surveillance cultures to bacteremia and fungemia in bone marrow transplant recipients with Hickman or Broviac catheters.J Surg Oncol. 1988 Nov;39(3):154-8. doi: 10.1002/jso.2930390304. J Surg Oncol. 1988. PMID: 3054334
-
Bacteremia and fungemia in the immunocompromised patient.Eur J Clin Microbiol Infect Dis. 1989 Sep;8(9):832-7. doi: 10.1007/BF02185856. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2512158 Review.
-
Bacteremia and fungemia in patients with neoplastic disease.Am J Med. 1987 Apr;82(4):723-30. doi: 10.1016/0002-9343(87)90007-6. Am J Med. 1987. PMID: 3565430
-
Intravenous catheter-related infections.Adv Pediatr Infect Dis. 1995;10:337-68. Adv Pediatr Infect Dis. 1995. PMID: 7718211 Review.
Cited by
-
Pneumonia caused by Micrococcus species in a neutropenic patient with acute leukemia.Eur J Clin Microbiol Infect Dis. 1997 Jul;16(7):546-8. doi: 10.1007/BF01708243. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9272395 No abstract available.
-
Implantable venous port-related infections in cancer patients.Support Care Cancer. 2004 Mar;12(3):197-201. doi: 10.1007/s00520-003-0576-z. Epub 2004 Jan 16. Support Care Cancer. 2004. PMID: 14727170
-
Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction.Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):247-53. doi: 10.1007/BF01699981. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9707307
-
Cloning and nucleotide sequence analysis of gyrB of Bacillus cereus, B. thuringiensis, B. mycoides, and B. anthracis and their application to the detection of B. cereus in rice.Appl Environ Microbiol. 1999 Apr;65(4):1483-90. doi: 10.1128/AEM.65.4.1483-1490.1999. Appl Environ Microbiol. 1999. PMID: 10103241 Free PMC article.
-
Micrococcus infection in patients receiving epoprostenol by continuous infusion.Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):704-5. doi: 10.1007/s10096-003-1024-1. Epub 2003 Oct 24. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14576986 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous